Human lymphoblastoid α-interferon for hairy cell leukemia. An update of the Italian Cooperative Group

Massimo Federico(University of Modena and Reggio Emilia), E Damasio(Istituto di Ematologia di Bologna), Teresa Lamparelli(Ospedale Policlinico San Martino), Giovanni Capnist(Ospedale San Bortolo), G. Pagnucco, Giulio Rossi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), L Resegotti, Teodoro Chisesi(Ospedale Civile di Venezia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), F. Lauria(Istituto di Ematologia di Bologna), C. Guarnaccia(Ospedale Vincenzo Cervello), C Bernasconi(University of Modena and Reggio Emilia)
Unknown
January 1, 1989
Cited by 2

Related Papers

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi
|Journal of Clinical Oncology|2013|262
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244